User login

Enter your username and password here in order to log in on the website:

Forgot your password?

05.08.2020

UEFA and SYNLAB work together to ensure the resumption of the UEFA competitions and matches in a safe environment

• SYNLAB appointed as “UEFA Laboratory Diagnostics Provider 2020/2021” for SARS-CoV-2 testing

• UEFA and SYNLAB have established a rigorous testing procedure to create an as safe as possible environment for players, officials and venue staff

• This procedure will enable the resumption of the UEFA competitions and matches for the remainder of this season, as well as the 2020/21 campaign


In the wake of the current COVID-19 pandemic, safety and well-being is an absolute priority. With that in mind, the UEFA, governing body of European football, and SYNLAB, the leading medical diagnostic services provider in Europe, have entered into a cooperation. Together, they create an as safe as possible environment through SARS-CoV-2 testing based on UEFA’s Return to Play Protocol. This enables the resumption of UEFA matches and competitions for the remainder of this season, as well as the 2020/21 campaign.

As part of the cooperation, SYNLAB will be the “UEFA Laboratory Diagnostics Provider 2020/2021” for SARS-CoV-2 testing across all UEFA competitions. To ensure the safety of all players and staff involved in the tournaments, UEFA and SYNLAB have established a procedure for rigorous testing in accordance with the applicable local laws and regulations as established by the competent national authorities:

  • Testing of all players and staff for SARS-CoV-2 ahead of every match using the RT-PCR or a medically equivalent testing method.
  • Sample collection and testing will be conducted by SYNLAB or one of its partners.
  • Only persons with negative results will be allowed for a match and have access to the stadium.

SYNLAB will ensure that SARS-CoV-2 testing for the UEFA competitions and matches will not result in any restrictions or limitations of testing capacities dedicated to the primary medical care at the respective locations. In the event of a shortage of testing capacities, the priority will be primary medical care.

Mathieu Floreani, CEO of SYNLAB Group: “We are proud UEFA chose SYNLAB as their provider for laboratory diagnostics, recognizing our medical excellence and geographic footprint in Europe. With our engagement for safe UEFA matches and competitions, we want to reconnect millions of fans with football, which is an important aspect of European culture.”

“The health of the players, staff, referees and everyone operating in the stadium is our main priority,” said UEFA deputy general secretary, Giorgio Marchetti. “This is why we are delighted to be partnering with an industry leader like SYNLAB who will help us ensure our competition matches are played in an as safe as possible environment.”

Download:
PDF: SYNLAB & UEFA Cooperation | Press release